| dc.contributor.author |
Doležalová, Barbora
|
cze |
| dc.contributor.author |
Flekač, Milan
|
cze |
| dc.date.accessioned |
2017-05-11T11:24:05Z |
|
| dc.date.available |
2017-05-11T11:24:05Z |
|
| dc.date.issued |
2016 |
cze |
| dc.identifier.issn |
1212-7299 |
cze |
| dc.identifier.uri |
http://hdl.handle.net/10195/67765 |
|
| dc.description.abstract |
V článku jsou diskutovány léčebné možnosti u dvou pacientů s diabetem 2. typu. V obou kazuistikách vedla léčba linagliptinem k dlouhodobému zajištění optimální kompenzace diabetu, a přitom umožnila pacientům aktivní životní styl bez rizika hypoglykemie či lékových interakcí. |
cze |
| dc.format |
p. 97-99 |
cze |
| dc.language.iso |
cze |
cze |
| dc.relation.ispartof |
Interní medicína pro praxi, volume 18, issue: 2 |
cze |
| dc.rights |
Pouze v rámci univerzity |
cze |
| dc.subject |
linagliptin |
cze |
| dc.subject |
diabetes mellitus 2. typu |
cze |
| dc.subject |
terapeutická strategie |
cze |
| dc.subject |
linagliptin |
eng |
| dc.subject |
type 2 diabetes mellitus |
eng |
| dc.subject |
therapeutic strategy |
eng |
| dc.title |
Linagliptin – diabetes bezpečně pod kontrolou již od začátku |
cze |
| dc.title.alternative |
Linagliptin – diabetes safely controlled from the very start |
eng |
| dc.type |
article |
cze |
| dc.description.abstract-translated |
This article presents case reports of two patients with type 2 diabetes in whom the use of linagliptin led to long-term excellent glycemic control, and offered the patients to maintain an active lifestyle without the risk of hypoglycaemia or drug interactions. |
eng |
| dc.peerreviewed |
yes |
cze |
| dc.publicationstatus |
published version |
cze |
| dc.identifier.scopus |
2-s2.0-84983740910 |
|
| dc.identifier.scopus |
2-s2.0-84983740910 |
|
| dc.identifier.obd |
39878591 |
cze |
